James G. Bollinger

4.5k total citations · 3 hit papers
40 papers, 3.1k citations indexed

About

James G. Bollinger is a scholar working on Molecular Biology, Physiology and Spectroscopy. According to data from OpenAlex, James G. Bollinger has authored 40 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 17 papers in Physiology and 7 papers in Spectroscopy. Recurrent topics in James G. Bollinger's work include Alzheimer's disease research and treatments (9 papers), Metabolomics and Mass Spectrometry Studies (7 papers) and Protein Kinase Regulation and GTPase Signaling (7 papers). James G. Bollinger is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Metabolomics and Mass Spectrometry Studies (7 papers) and Protein Kinase Regulation and GTPase Signaling (7 papers). James G. Bollinger collaborates with scholars based in United States, France and United Kingdom. James G. Bollinger's co-authors include Michael H. Gelb, Michael J. MacCoss, Brian C. Searle, Brook L. Nunn, Lindsay K. Pino, Brendan MacLean, Randall J. Bateman, Vitaliy Ovod, Kwasi G. Mawuenyega and Suzanne E. Schindler and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

James G. Bollinger

39 papers receiving 3.0k citations

Hit Papers

High-precision plasma β-amyloid 42/40 predicts current an... 2017 2026 2020 2023 2019 2017 2024 100 200 300 400 500

Peers

James G. Bollinger
Comparison fields: 5 of 132
  • Molecular Biology 1.5k
  • Physiology 931
  • Spectroscopy 545
  • Psychiatry and Mental health 532
  • Immunology 269
Alfred N. Fonteh United States
Amrita K. Cheema United States
Loı̈c Dayon Switzerland
Vladislav Petyuk United States
Tom J. de Koning Netherlands
Hua Cheng China
Richard D. Unwin United Kingdom
C. Jakobs Netherlands
Rebecca Baillie United States
Tilo Großer United States
Alfred N. Fonteh United States View profile →
Citations per field, relative to James G. Bollinger
James G. Bollinger · 1×
Citations per year, relative to James G. Bollinger
James G. Bollinger · 1×

Countries citing papers authored by James G. Bollinger

Since Specialization
Citations

This map shows the geographic impact of James G. Bollinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James G. Bollinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James G. Bollinger more than expected).

Fields of papers citing papers by James G. Bollinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James G. Bollinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James G. Bollinger. The network helps show where James G. Bollinger may publish in the future.

Co-authorship network of co-authors of James G. Bollinger

This figure shows the co-authorship network connecting the top 25 collaborators of James G. Bollinger. A scholar is included among the top collaborators of James G. Bollinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James G. Bollinger. James G. Bollinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Alzheimer’s disease blood tests of amyloid‐beta 42/40, %p‐tau217, 181, and 205 ratios and MTBR‐243 in real‐world populations: Results from SEABIRD and BioFINDER2 Alzheimer s & Dementia Randall J. Bateman, Melody Li et al. 0
2 Suvorexant Acutely Decreases Tau Phosphorylation and Aβ in the Human CNS Annals of Neurology Brendan P. Lucey, Haiyan Liu et al. 46
3 Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40 Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring Julie K. Wisch, Brian A. Gordon et al. 14
4 The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review Alzheimer s Research & Therapy James G. Bollinger, Yan Li et al. 79
5 The Skyline ecosystem: Informatics for quantitative mass spectrometry proteomics breakdown → Mass Spectrometry Reviews Lindsay K. Pino, Brian C. Searle et al. 480
6 Identification of Epithelial Phospholipase A2 Receptor 1 as a Potential Target in Asthma American Journal of Respiratory Cell and Molecular Biology James D. Nolin, Ying Lai et al. 29
7 Human Central Nervous System (CNS) ApoE Isoforms Are Increased by Age, Differentially Altered by Amyloidosis, and Relative Amounts Reversed in the CNS Compared with Plasma Journal of Biological Chemistry Alaina Baker‐Nigh, Kwasi G. Mawuenyega et al. 42
8 Using Data Independent Acquisition (DIA) to Model High-responding Peptides for Targeted Proteomics Experiments Molecular & Cellular Proteomics Brian C. Searle, Jarrett D. Egertson et al. 35
9 Regulation and Function of Epithelial Secreted Phospholipase A2 Group X in Asthma American Journal of Respiratory and Critical Care Medicine Teal S. Hallstrand, Ying Lai et al. 38
10 Key Role of Group V Secreted Phospholipase A2 in Th2 Cytokine and Dendritic Cell-Driven Airway Hyperresponsiveness and Remodeling PLoS ONE William R. Henderson, Xin Ye et al. 19
11 LC/ESI-MS/MS detection of FAs by charge reversal derivatization with more than four orders of magnitude improvement in sensitivity Journal of Lipid Research James G. Bollinger, Martin Sadı́lek et al. 100
12 Blockade of Human Group X Secreted Phospholipase A2 (GX-sPLA2)-induced Airway Inflammation and Hyperresponsiveness in a Mouse Asthma Model by a Selective GX-sPLA2 Inhibitor Journal of Biological Chemistry William R. Henderson, Rob Oslund et al. 35
13 Role of Phosphorylation and Basic Residues in the Catalytic Domain of Cytosolic Phospholipase A2α in Regulating Interfacial Kinetics and Binding and Cellular Function Journal of Biological Chemistry Dawn E. Tucker, Moumita Ghosh et al. 42
14 Improved method for the quantification of lysophospholipids including enol ether species by liquid chromatography-tandem mass spectrometry Journal of Lipid Research James G. Bollinger, Martin Sadı́lek et al. 44
15 Group X Phospholipase A2 Stimulates the Proliferation of Colon Cancer Cells by Producing Various Lipid Mediators Molecular Pharmacology Éric Boilard, James G. Bollinger et al. 48
16 Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development Nature Medicine Robert L. Wilensky, Yi Shi et al. 294
17 Importance of group X–secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model The Journal of Experimental Medicine William R. Henderson, Y. Emil et al. 160
18 C-terminal proteolysis of prenylated proteins in trypanosomatids and RNA interference of enzymes required for the post-translational processing pathway of farnesylated proteins Molecular and Biochemical Parasitology J. Robert Gillespie, Kohei Yokoyama et al. 16
19 The proinflammatory mediator Platelet Activating Factor is an effective substrate for human group X secreted phospholipase A2 Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids Sarah Gora, Gérard Lambeau et al. 19
20 On the Binding Preference of Human Groups IIA and X Phospholipases A2 for Membranes with Anionic Phospholipids Journal of Biological Chemistry Sofiane Bezzine, James G. Bollinger et al. 111

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026